journal article

PCN78 COST-EFFECTIVENESS ASSESSMENT OF ZOLEDRONIC ACID (ZOL) RELATIVE TO PLACEBO (PBO) IN THE TREATMENT OF LUNG CANCER PATIENTS WITH SKELETAL METASTASES IN FIVE EUROPEAN COUNTRIES

Authors
Publication date
1 October 2009
Publisher
International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Elsevier - Publisher Connector

      redirect
      oaidoi:10.1016/S1098-3015(10)7432...
      Last time updated on 05/05/2017

      Elsevier - Publisher Connector

      redirect
      oaidoi:10.1016/S1098-3015(10)7432...
      Last time updated on 05/06/2019

      Crossref

      redirect
      oaiinfo:doi/10.1016%2Fs1098-3015%...
      Last time updated on 05/06/2019